Biotech company Regeneron to buy bankrupt 23andMe for $256M
Ars Technica   14 days ago
ads
Read Full Story
Biotech company Regeneron to buy bankrupt 23andMe for $256M  Ars TechnicaRegeneron to buy bankrupt DNA testing firm 23andMe for $256 million  CNN23andMe to Be Bought by Biotech Company for $256 Million  The New York TimesRegeneron to Buy 23andMe...